Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Title
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
Authors
Keywords
B cells, Drug screening, T cells, Protein structure databases, Kinase inhibitors, Protein kinases, RNA interference, Drug interactions
Journal
PLoS One
Volume 15, Issue 5, Pages e0233089
Publisher
Public Library of Science (PLoS)
Online
2020-05-28
DOI
10.1371/journal.pone.0233089

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More